FDA advisers recommend stronger warnings for Yaz, Yasmin birth control pills
Friday, December 9, 2011
Washington Post: “A popular new generation of birth control pills should carry stronger warnings about the risks they pose of potentially life-threatening blood clots, federal advisers recommended,” according to Rob Stein. Members of two U.S. Food and Drug Administration committees voted that the current labels on Yaz and Yasmin, both products of Bayer, fail to provide adequate warning about the potential of blood clots. But the committees also voted that “the benefits of the pills in preventing unwanted pregnancies outweighed the risks,” Stein reports.